Search results
Q3 2024 EPS Estimates for Novavax, Inc. Reduced by Zacks Research (NASDAQ:NVAX)
ETF DAILY NEWS· 2 weeks agoNovavax, Inc. (NASDAQ:NVAX – Free Report) – Stock analysts at Zacks Research decreased their Q3 2024 EPS estimates for shares of Novavax in a research report ...
These Biotech Stocks Could Soar 120% and 295%, According to Wall Street
Motley Fool via Yahoo Finance· 4 days agoThe company aims to bring its vaccine to market in early September, make it available in a...
Analysts Expect Moderna's First-Quarter Sales To Plummet 95% — Is Moderna Stock A Sell?
Investor's Business Daily· 22 hours agoWhat's After Covid Shots? Investors are paying close attention to the bespoke cancer vaccine in...
OHA study finds no link between COVID-19 vaccine and cardiac deaths
The Columbian· 2 weeks agoThe study found no one died within the first 100 days of receiving an mRNA COVID-19 vaccine which...
Less than half of nursing home residents are up to date with their COVID-19 vaccines, study finds:...
Yahoo Life· 3 days agoHere’s your go-to guide with everything you need to know about COVID-19, including testing expanding...
On eve of Japanese prime minister's visit to North Carolina, Fujifilm announces more jobs there
FOX 25 Boston· 2 weeks agoGov. Roy Cooper joined a company executive and local government leaders in unveiling an additional...
The Path to a Better Tuberculosis Vaccine Runs Through Montana
US News & World Report· 1 week agoThe BCG (Bacille Calmette-Guérin) vaccine, created in 1921, remains the sole TB vaccine. One effort is underway at the University of Montana Center for ...
COVID Vaccinations Less Prevalent in Marginalized Patients
Medscape· 1 week ago"The family physicians with the most unvaccinated patients were also more likely to be solo...
4 Years In, a Sobering Look at Long COVID Progress
Medscape· 1 week agoFour years ago in the spring of 2020, physicians and patients coined the term "long COVID" to describe a form of the viral infection from which recovery...